Aprogen KIC Inc

KO:007460 Korea Conglomerates
Market Cap
$63.61 Million
₩93.14 Billion KRW
Market Cap Rank
#22240 Global
#1117 in Korea
Share Price
₩320.00
Change (1 day)
+1.91%
52-Week Range
₩306.00 - ₩910.00
All Time High
₩51600.00
Categories
Companies in Korea Conglomerates
About

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation syst… Read more

Aprogen KIC Inc (007460) - Net Assets

Latest net assets as of September 2025: ₩488.30 Billion KRW

Based on the latest financial reports, Aprogen KIC Inc (007460) has net assets worth ₩488.30 Billion KRW as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩811.82 Billion) and total liabilities (₩323.51 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩488.30 Billion
% of Total Assets 60.15%
Annual Growth Rate 15.46%
5-Year Change -36.23%
10-Year Change N/A
Growth Volatility 104.69

Aprogen KIC Inc - Net Assets Trend (2002–2024)

This chart illustrates how Aprogen KIC Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Aprogen KIC Inc (2002–2024)

The table below shows the annual net assets of Aprogen KIC Inc from 2002 to 2024.

Year Net Assets Change
2024-12-31 ₩440.09 Billion +5.36%
2023-12-31 ₩417.69 Billion -9.40%
2022-12-31 ₩461.00 Billion -34.55%
2021-12-31 ₩704.36 Billion +2.06%
2020-12-31 ₩690.14 Billion +30.97%
2019-12-31 ₩526.95 Billion +169.53%
2018-12-31 ₩195.51 Billion +30.73%
2017-12-31 ₩149.56 Billion +323.47%
2016-12-31 ₩35.32 Billion +584.73%
2012-12-31 ₩-7.29 Billion -215.33%
2011-12-31 ₩6.32 Billion -93.88%
2010-12-31 ₩103.28 Billion -12.51%
2009-12-31 ₩118.05 Billion +5.17%
2008-12-31 ₩112.25 Billion +89.55%
2007-12-31 ₩59.22 Billion +77.67%
2006-12-31 ₩33.33 Billion +28.29%
2005-12-31 ₩25.98 Billion +29.94%
2004-12-31 ₩19.99 Billion +8.77%
2003-12-31 ₩18.38 Billion -1.28%
2002-12-31 ₩18.62 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Aprogen KIC Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 41850615408000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components ₩577.14 Billion 363.82%
Total Equity ₩158.63 Billion 100.00%

Aprogen KIC Inc Competitors by Market Cap

The table below lists competitors of Aprogen KIC Inc ranked by their market capitalization.

Company Market Cap
Vistin Pharma ASA
OL:VISTN
 		$40.47 Million
ICC Holdings Inc
NASDAQ:ICCH
 		$40.47 Million
Gentian Diagnostics AS
OL:GENT
 		$40.48 Million
Ambika Cotton Mills Limited
NSE:AMBIKCO
 		$40.48 Million
SDN Company. Ltd
KQ:099220
 		$40.47 Million
CAPITAL + REGIONAL LS-01
F:XC2R
 		$40.47 Million
Eusu Holdings
KO:000700
 		$40.44 Million
Peoples Financial Corp
OTCQX:PFBX
 		$40.43 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Aprogen KIC Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 147,799,582,690 to 158,633,660,420, a change of 10,834,077,730 (7.3%).
  • Net loss of 58,079,234,210 reduced equity.
  • Share repurchases of 97,750 reduced equity.
  • New share issuances of 761,300 increased equity.
  • Other factors increased equity by 68,912,648,390.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩-58.08 Billion -36.61%
Share Repurchases ₩97.75K -0.0%
Share Issuances ₩761.30K +0.0%
Other Changes ₩68.91 Billion +43.44%
Total Change ₩- 7.33%

Book Value vs Market Value Analysis

This analysis compares Aprogen KIC Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.57x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.11x to 0.57x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 ₩3004.77 ₩320.00 x
2018-12-31 ₩2127.44 ₩320.00 x
2019-12-31 ₩1973.34 ₩320.00 x
2020-12-31 ₩1744.12 ₩320.00 x
2021-12-31 ₩1686.90 ₩320.00 x
2022-12-31 ₩923.44 ₩320.00 x
2023-12-31 ₩605.54 ₩320.00 x
2024-12-31 ₩559.82 ₩320.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Aprogen KIC Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -36.61%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -38.69%
  • • Asset Turnover: 0.25x
  • • Equity Multiplier: 3.85x
  • Recent ROE (-36.61%) is below the historical average (-11.13%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 13.38% 3.31% 1.09x 3.71x ₩628.64 Million
2003 12.19% 2.67% 0.89x 5.13x ₩402.92 Million
2004 9.62% 2.07% 0.95x 4.91x ₩-76.39 Million
2005 16.57% 3.97% 1.02x 4.10x ₩1.71 Billion
2006 20.74% 6.54% 0.82x 3.86x ₩3.58 Billion
2007 12.08% 5.34% 0.81x 2.81x ₩1.19 Billion
2008 8.75% 3.57% 0.98x 2.51x ₩-1.39 Billion
2009 3.76% 1.94% 0.71x 2.74x ₩-7.30 Billion
2010 -12.40% -5.51% 0.68x 3.31x ₩-23.10 Billion
2011 -132.80% -41.76% 0.33x 9.64x ₩-51.92 Billion
2012 -30.18% -7.07% 0.50x 8.56x ₩-16.07 Billion
2016 6.82% 4.39% 0.70x 2.22x ₩-1.12 Billion
2017 1.57% 5.21% 0.17x 1.79x ₩-12.61 Billion
2018 -16.42% -62.90% 0.13x 2.02x ₩-51.66 Billion
2019 3.86% 14.97% 0.12x 2.16x ₩-18.62 Billion
2020 -14.57% -36.57% 0.15x 2.62x ₩-78.40 Billion
2021 -5.36% -12.75% 0.17x 2.45x ₩-51.60 Billion
2022 -45.87% -125.92% 0.13x 2.79x ₩-120.17 Billion
2023 -37.63% -36.94% 0.25x 4.02x ₩-70.40 Billion
2024 -36.61% -38.69% 0.25x 3.85x ₩-73.94 Billion

Industry Comparison

This section compares Aprogen KIC Inc's net assets metrics with peer companies in the Conglomerates industry.

Industry Context

  • Industry: Conglomerates
  • Average net assets among peers: $5,885,751,880,295
  • Average return on equity (ROE) among peers: 1.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Aprogen KIC Inc (007460) ₩488.30 Billion 13.38% 0.66x $40.47 Million
Doosan (000150) $3.17 Trillion 2.32% 4.42x $7.78 Billion
Doosan Pref Shs (000155) $7.71 Trillion -7.18% 2.91x $3.91 Billion
Doosan Co Ltd (000157) $7.15 Trillion -1.64% 3.04x $833.50 Million
Hanwha Corp. Pfd. Series 1 (000885) $13.65 Trillion -2.09% 9.67x $738.15 Million
Hanwha Corp Preferred (00088K) $14.23 Trillion 3.46% 9.88x $892.93 Million
Cj Corp Pref  (001045) $9.86 Trillion 2.09% 1.39x $914.06 Million
LX International Corp (001120) $654.45 Billion 14.28% 3.82x $773.58 Million
Kg Chemical (001390) $192.43 Billion 3.19% 1.23x $130.84 Million
SK Networks Co Ltd (001740) $2.25 Trillion 1.54% 2.91x $348.44 Million
Hanchang (005110) $3.47 Billion 0.00% 16.09x $12.60 Million